Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2002
03/26/2002US6361935 Waxy wheat starch types having waxy proteins in granule
03/26/2002US6361808 Preparing alcoholic beveroge, heating, steeping or mixing
03/26/2002US6361776 Polypeptide isolated from mycobacterium vaccae comprising specified amino acid sequence, capable of eliciting and/or enhancing immune response to heterologous antigen
03/26/2002US6361773 Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
03/26/2002US6361772 Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase
03/26/2002CA2232727C Novel variants of green fluorescent protein, gfp
03/26/2002CA2099876C Production of enzymatically active glucocerebrosidase from recombinant cells
03/26/2002CA2055698C Peroxidase gene of microbial origin
03/26/2002CA1341352C Cloning and utilization of aminotransferase genes
03/22/2002CA2357526A1 Mannosidase structures
03/21/2002WO2002022943A1 Method of deinking waste paper by using cellulase without lowering paper strength and method of evaluating the same
03/21/2002WO2002022882A2 Target activated nucleic acid biosensor and methods of using same
03/21/2002WO2002022876A1 Method of identifying putative antibiotic resistance genes
03/21/2002WO2002022869A2 Directed evolution method
03/21/2002WO2002022861A1 Oxygenase enzymes and screening method
03/21/2002WO2002022832A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein
03/21/2002WO2002022831A1 Thermotolerant ribonuclease h
03/21/2002WO2002022830A2 Transglutaminase gene products
03/21/2002WO2002022829A2 Nucleotide sequences which code for the ppsa gene
03/21/2002WO2002022828A1 Isolation and sequencing of the pknb gene of c. glutamicum
03/21/2002WO2002022827A1 Isolation and sequences of the ptsi gene of c. glutamicum
03/21/2002WO2002022819A2 Calcium binding proteins
03/21/2002WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
03/21/2002WO2002022799A2 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof
03/21/2002WO2002022796A1 Calcium free subtilisin mutants
03/21/2002WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
03/21/2002WO2002022794A2 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE
03/21/2002WO2002022793A1 Crystal structure of pantothenate synthetase
03/21/2002WO2002022792A2 Nucleic acid molecules encoding a poly(adp-ribose) polymerase
03/21/2002WO2002022791A2 Regulation of human pyridoxine 5'-phosphate oxidase
03/21/2002WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription
03/21/2002WO2002022779A2 High level expression of heterologous proteins
03/21/2002WO2002022777A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
03/21/2002WO2002022776A2 Human coagulation factor vii variants
03/21/2002WO2002022666A2 Nucleotide sequences which code for the gora gene
03/21/2002WO2002022661A2 NOVEL PDEs AND USES THEREOF
03/21/2002WO2002022632A2 Nucleotide sequences coding for the pknd gene
03/21/2002WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme
03/21/2002WO2002022629A1 Anti-stilbene antibodies
03/21/2002WO2002022527A2 Design and production of mutant 2,5-diketo-d-gluconic acid reductase enzymes with altered cofactor dependency
03/21/2002WO2002022169A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
03/21/2002WO2002022103A1 Cosmetic compositions
03/21/2002WO2002021925A1 Pest control system
03/21/2002WO2001085800A3 Esterified polysaccharide products and η-lactone ring opened ketene dimer products containing the compositions, and process of making the same
03/21/2002WO2001079434A3 A novel polypeptide, a human signal peptidase 10 and the polynucleotide encoding the polypeptide
03/21/2002WO2001077341A3 Mammalian heparanase
03/21/2002WO2001077307A3 Expression system for efficiently producing clinically effective lysosomal enzymes (glucocerebrosidase)
03/21/2002WO2001075047A3 Novel polypeptide - a human flavoprotein sununit 10 and polynucleotide encoding it
03/21/2002WO2001075016A3 A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
03/21/2002WO2001075013A3 Novel polypeptide - a human cyclin dependent kinase 14 and polynucleotide encoding it
03/21/2002WO2001068871A3 Human phospholipases and polynucleotides encoding the same
03/21/2002WO2001068870A3 S-adenosyl-l-methionine:phosphoethanolamine n-methyltransferase compositions and methods for modulating lipid biosynthesis in plants
03/21/2002WO2001068818A3 Hcv ns2/3 fragments and uses thereof
03/21/2002WO2001066771A3 Human serine protease
03/21/2002WO2001066763A3 23436, a human ubiquitin protease family member and uses thereof
03/21/2002WO2001066757A8 25934, a novel fatty acid desaturase and uses therefor
03/21/2002WO2001064928A3 Transgenic plants with increased seed yield, biomass and harvest index
03/21/2002WO2001064919A3 18036, a novel calpain-like protease and uses thereof
03/21/2002WO2001064851A3 32670, novel human phosphatidylserine synthase-like molecules and uses thereof
03/21/2002WO2001064840A8 Novel bone marrow nucleic acids and polypeptides
03/21/2002WO2001062905A3 Integrin antagonists
03/21/2002WO2001062889A8 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
03/21/2002WO2001060991A3 Human kinases
03/21/2002WO2001060990A3 Sphingosine kinases
03/21/2002WO2001057221A3 Dsp-12 and dsp-13 dual-specificity phosphatases
03/21/2002WO2001055411A3 Human sulfatases
03/21/2002WO2001051638A3 Drug metabolizing enzymes
03/21/2002WO2001049835A3 Molecules that influence pathogen resistance
03/21/2002WO2001048230A3 Modified dhps genes
03/21/2002WO2001029232A3 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
03/21/2002US20020035740 Generating plants with intensified propagation characteristics; obtain cells, transform cells, monitor plastids of genetically engineered plant for preferential gene expression
03/21/2002US20020035733 Congenic animal models of non-insulin dependent diabetes mellitus
03/21/2002US20020035245 Recombinant vanadium haloperoxidases and their uses
03/21/2002US20020035242 Antibody binding
03/21/2002US20020035241 Process for the separation and/or isolation of plasma proteins by means of annular chromatography
03/21/2002US20020035240 Novel mammalian cell cycle protein
03/21/2002US20020035078 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity
03/21/2002US20020035072 Method for enhancing mutant enzyme activities in lysosomal storage disorders
03/21/2002US20020034816 Genetically engineered gram-positive bacterium for the generation of ethyl alcohol
03/21/2002US20020034813 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging
03/21/2002US20020034812 Caspase homologue
03/21/2002US20020034811 Method for removal of protease activity from amylase
03/21/2002US20020034810 Preferential nucleotide sequences for use in prevention of bacterial, viral and protozoan infection; for use in treatment of nervous system disorders
03/21/2002US20020034808 Crystal of bacterial core RNA polymerase
03/21/2002US20020034807 Nucleotide sequences coding enzymatic proteins; for use in the treatment of cell proliferation and differention disorders; antiproliferative agents
03/21/2002US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
03/21/2002US20020034805 Nucleotide sequences coding enzymatic polypepties for use in development of anticarcinogenic agents
03/21/2002US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/21/2002US20020034801 Nucleotide sequences coding redox proteins for use in treatment of cell proliferative, diffentiation and cardiovascular disorders
03/21/2002US20020034798 High-activity phytase compositions
03/21/2002US20020034797 Modified modular pks with retained scaffold
03/21/2002US20020034794 Nucleotide sequences which encode the gpsA gene
03/21/2002US20020034789 Isolated proteins containing portions of fapalpha and other proteins
03/21/2002US20020034783 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of tumors; antitumor agents
03/21/2002US20020034780 Novel human protein kinases and uses therefor
03/21/2002US20020034779 Novel argS
03/21/2002US20020034776 Genetically engineering enzymatic proteins; transform eschericha, generate mutations, transmit mutation to another microoganism and detect enzymatic activity, recover microorganism with adjusted enzymatic activity
03/21/2002US20020034767 Screening for modulators of enzymatic activity; incubate sample with modulators, detect adjustment in enzymatic activity, adjustment in enzymatic activity indicates modulator
03/21/2002US20020034746 Computer program product for quantitative analysis of a nucleic acid amplification reaction
03/21/2002US20020034745 Device for determining transition point in cycled propagation reaction; for use as diagnostic tools in nucleotide sequences analysis
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 1416